1. Home
  2. SIMO vs IBRX Comparison

SIMO vs IBRX Comparison

Compare SIMO & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$113.56

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$6.23

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
IBRX
Founded
1995
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
SIMO
IBRX
Price
$113.56
$6.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$105.00
$11.80
AVG Volume (30 Days)
715.1K
46.1M
Earning Date
02-03-2026
03-02-2026
Dividend Yield
1.77%
N/A
EPS Growth
8.75
N/A
EPS
2.87
N/A
Revenue
$798,326,000.00
$82,555,000.00
Revenue This Year
$10.15
$680.06
Revenue Next Year
$16.36
$90.18
P/E Ratio
$39.35
N/A
Revenue Growth
N/A
1025.95
52 Week Low
$37.21
$1.83
52 Week High
$127.67
$8.28

Technical Indicators

Market Signals
Indicator
SIMO
IBRX
Relative Strength Index (RSI) 61.78 75.41
Support Level $111.00 $5.71
Resistance Level $127.67 $8.28
Average True Range (ATR) 9.29 0.67
MACD 0.00 0.42
Stochastic Oscillator 57.43 67.10

Price Performance

Historical Comparison
SIMO
IBRX

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: